In contrast to their well-documented toxicity in vivo, aminoglycosides have no acute toxicity to either cochlear or renal cells in vitro [5, 61. This discrepancy between in vivo and in vitro effects suggests that a metabolic event is required for the toxic actions of these antibiotics. The possibility of aminoglycoside-delved toxic metabolites has seldom been considered, and direct experimental evidence for such metabolites has been lacking [7, 81. Indeed, it has remained dogma that these drugs do not undergo significant metabolism prior to their renal elimination [9] .
In this study, we used isolated cochlear outer hair cells in a recently developed cytotoxieity assay (5, lo] to test the toxicity of aminoglycosides after incubation with drug-metabolizing hepatic enzymes. The subcellular S9 fraction employed (9000 g supernatant from phenobarbital-treated animals) has been well-established for xenobiotic metabolism in the Ames test [ll] . Gentami~in incubated with the hepatic enzymes decreased the viability of the cells, while the untreated parent antibiotic had no cytotoxic effect; evidence for the involvement of oxidative metabolism in the formation of the toxic metabolite is provided. These results should lead to new rational approaches to the mechanism and prevention of aminoglycoside-induced toxicity.
METHODS
Liver homogenates (3 mL of 0.15 M KCl/g liver, dispersed with a Brinkmann Polytron for 10 set) from guinea pigs treated with phenob~bital (0.1% in inking water for 10 days) were centrifuged at 9000 g for 10 min and the supematants (S9) stored at -80° in glass vials. The S9 fraction was combined for each experiment with 100 mM sodium phosphate buffer (pH 7.40), 4 mM NADP, 5 mM glucose-6-phosphate, 30 mM KC1 and 7 mM MgCl2 [ 111, and 10 mM gentamicin sulfate (Sigma, St. Louis, MO) was incubated with this 59 Mix" at a protein concentration of 4 f 1 mg/mL for 60 min at 37' in giass tubes. The incubation mixture was heat-treated (5~5~ for 1.5 min) to remove protein without inactivating the metabolite, centrifuged (10,000 g for 10 min), and kept on ice.
Outer hair cells were isolated from the three upper cochlear turns of pigmented guinea pigs (200-300 g) by micr~issection and brief treatment with collagenase (0.5 mg/mL for 10 min). They were m~ntained at room temperature in Hanks' Balanced Salt Solution without bicarbonate, buffered with 5 mM HEPES, pH 7.40, and osmolarity adjusted with NaCl to 300 mOsM [12] . To assay cytotoxicity, isolated hair cells were exposed at room temperature to a 1: 10 dilution (v/v) of the deproteinated incubation medium in droplets of Hanks' solution.
Viability was quantitated based on the exclusion of the nuclear dye propidium iodide, added immediately prior to cell counting (final concentration, 4 PM). Stained or enucleated cells were counted as dead.
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RESULTS
Metabolism of gentamicin.
After incubation with the S9 Mix, metabolized gentamicin significantly decreased the viability of cochlear outer hair cells ( Figure I and Table I ). This was accompanied by mo~hologi~ evidence of cell destruction, such as swelling, vacuolization, granularity, loss of birefringence and occasional enucleation. In contrast, unmetabolized gentamicin was not cytotoxic under these conditions ( Figure I ), in agreement with our previous data [S] .
Incubations of the S9 Mix without aminoglycoside antibiotic produced no apparent cytotoxic effect, demons~ting the absence of intrinsic toxic substances in the subcell&r fraction (Table I) Figure I . Time course of cytotoxicity of metabolized gentamicin. The viability of isolated outer hair cells was assessed as described in Methods after exposure to: gentamicin-free Hanks' medium ( 0 ), gentamicin incubated with S9 Mix (A ), or gentamicin in a reagent blank without the S9 fraction (V ). Each value is derived from observations of at least 100 cells. The viabili~ of isolated cochlear outer hair cells was dete~ined as described in Methods after a 75-min exposure at room temperature to: {a) gentamicin incubated with S9 Mix; (b) S9 Mix incubated without gentamicin; (cl gentamicin incubated with a heat-inactivated S9 fraction ( 100° for 1.5 min) in the Mix. For each condition, mean viability + SD was determined from the number of independent experiments and total number of cells indicated.
Statistical significance of differences: 'S9 + gentamicin' differed significantly (P < 0.001; twosample t-test) from each of the other conditions. 'S9 alone' and 'heated S9 + gentamicin' were not different from controls in Hanks' medium.
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Inhibition of gentamicin metabolism. Hepatic drug metabolism is frequently associated with cytochrome P450 or similar oxygenases.
To assess the possible contribution of such enzymes, oxidative reactions were suppressed in the incubation (Table II) . Two independent approaches were employed: NADP was omitted to prevent the generation of NADPH, and ketoconazole was added as a broad-spectrum inhibitor of oxidative xenobiotic metabolism [14, 151. Under both conditions, the formation of a toxic product was essentially prevented and outer hair cells remained viable. These results strongly suggest a role for mono-oxygenases in the metabolism of aminoglycosides. Oxidative metabolism was inhibited by omission of NADP from or addition of 250 pM ketoconazole (in 0.5% aqueous ethanol, v/v) to the S9 Mix as noted in the table. The viability of isolated outer hair cells was assessed as described in Methods after a 75min exposure at room temperature to each condition indicated. Mean viability + SD was dete~in~ from the number of independent experiments and total number of cells indicated. Statistical significance of differences: 'S9 f gentamicin' was significantly different (P : 0.001; two-sample t-test) from each of the other conditions. 'NADP omitted and 'ketoconazole added were not different from control incubations in Hanks' medium.
DISCUSSION
Our data provide the first direct demonstration that metabolism is required for the cytotoxicity of aminoglycosides. While several pathways appear compatible with the data at this point, an enzymatic oxidation producing one or more cytotoxic metabolites from gentamicin appears the most likely reaction. Regardless of the mechanism, the novel and important aspect of these results is the fact that the cytotoxic species is not the parent ~inoglycoside but a metabolite which is stable for at least several hours following mild heat treatment.
The existence of a toxic metabolic product may explain why it has been exceedingly difficult to formulate a molecular mechanism of aminoglycoside toxicity. For example, the appearance of nephrotoxicity and ototoxicity is delayed for days to weeks, despite early peak drug levels in both cochlear and renal tissues 1161. The requirement for a toxic metabolite coutd account for the poor correlation between aminoglycoside concentrations and the histopathologic damage to either target organ [9, , and the delay in onset of clinical toxicity could represent either the time necessary for induction of the metabolizing enzymes or for the metabolite to reach toxic levels.
The extent of metabolism of aminoglycosides in vivo is unknown. It is conceivable, however, that the concentration of the cytotoxic metabolite(s) is relatively low, having thus escaped traditional methods of detection.
Only the development of outer hair cell isolation [19, 201 and the novel bioassay used here enabled direct measurement of cytotoxicity with adequately high sensitivity.
Further investigation will determine the intracellular location and the inducibility of the metabolizing enzyme(s), as well as the chemical structure of the potential metabolite(s). Considering the tissue specificity of aminoglycoside toxicity, it needs to be established to what extent this metabolism occurs in extra-hepatic tissues,
A contribution by local metabolism to the development of organ-specific toxicity is suggested by reports that
